NOWDx Submits De Novo Classification Request to the FDA for OTC Syphilis Test
NOWDiagnostics submitted a De Novo Classification Request to the U.S. FDA for the company's First to Know at-home syphilis test.
NOWDiagnostics submitted a De Novo Classification Request to the U.S. FDA for the company's First to Know at-home syphilis test.
The US DHA has awarded Daxor a $1.1 million SBIR contract to add EMR integration to its battery-powered blood volume analyzer.
Cue Health announced that it has made a De Novo submission to the FDA for full clearance of the Cue RSV Molecular Test.
The August/September 2022 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
Researchers have developed an ultrafast PCR technology that shortens test time by 10-fold, compared with time taken for the existing test.
Bacterial vaginosis and trichomoniasis results in a range of health complications. A test-and-treat approach can improve diagnosis.